About Meyonex Pharmaceuticals Limited
Data last updated: 22 December 2025
Meyonex Pharmaceuticals Limited is a public limited company based in Palghar, Maharashtra, India, recognised as a startup by DPIIT. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 17 January 2015, the company has been in operation for over 11 years.
Registered with ROC Mumbai under CIN U74120MH2015PLC261024.
Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹14 Cr. Formerly known as Aveo Pharmaceuticals Limited. It is led by directors including Arvind Awadhnath Sharma and Vinod Kumar Sharma.
Last AGM: 28 September 2024. Financial statements filed for year ended 31 March 2024. Office: Plot No C – 13 Midc Tarapur Palghar, Maharashtra, India – 401506.
As per the financials filed for FY 2025, the company reported a revenue of ₹108.15 Cr, a decline of 19% compared to the previous year.
The company has a workforce of approximately 48 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Aveo Pharmaceutical. As per MCA filings, the company has open charges of ₹21.02 Cr and satisfied charges of ₹25 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aveo.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressPlot No C – 13 Midc Tarapur Palghar, Maharashtra, India – 401506
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Meyonex Pharmaceuticals Limited
Meyonex Pharmaceuticals Limited has one previous CIN (Corporate Identification Number): U74120MH2015PTC261024. The current CIN is U74120MH2015PLC261024, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74120MH2015PLC261024 | Current |
| U74120MH2015PTC261024 | Previous |
Associated Brands with Meyonex Pharmaceuticals Limited
Meyonex Pharmaceuticals Limited operates one associated brand: Aveo Pharmaceutical. These brands represent Meyonex Pharmaceuticals Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Drug manufacturing and marketing services are provided by Aveo Pharmaceutical. | aveo.in |
Competitors & Alternatives of Meyonex Pharmaceuticals Limited
Brands and companies operating in the same space as Meyonex Pharmaceuticals Limited include Novartis, Surrozen, Catalent and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Novartis
|
R&D focused on manufacturing of drugs for multiple therapeutic areas | Basel, Switzerland, Switzerland | 1996 |
Surrozen
|
Selective Wnt agonists are developed for human tissue regeneration. | San Francisco, United States, United States | 2016 |
Catalent
|
CDMO offering drug and biologics development services | Somerset, United States, United States | 2007 |
Biotage
|
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development | Uppsala, Sweden, Sweden | 2009 |
Tirupati Medicare
|
Pharmaceutical products are manufactured under contract by Tirupati Medicare. | Paonta Sahib, India, India | 1980 |
Curia
|
Drug research, development, testing, and consulting services are provided. | Albany, United States, United States | 1991 |
WuXi Biologics
|
Protein therapeutics are developed and manufactured by WuXi Biologics. | Shanghai, China, China | 2008 |
AmplifyBio
|
Provides contract research, development, and manufacturing services for biologic drugs. | Hilliard, United States, United States | 2021 |
Indapta
|
Limited information available | Seattle, United States, United States | 2016 |
Business Activity of Meyonex Pharmaceuticals Limited
Meyonex Pharmaceuticals Limited is engaged in principal business activities including trade and manufacturing, with detailed activities including wholesale trading, chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Meyonex Pharmaceuticals Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Meyonex Pharmaceuticals Limited
Meyonex Pharmaceuticals Limited is audited by ATUL JAISWAL & ASSOCIATES for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ATUL JAISWAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Meyonex Pharmaceuticals Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Meyonex Pharmaceuticals Limited
Meyonex Pharmaceuticals Limited is currently managed by 3 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Awadhnath Sharma | Director | 17 Jan 2015 | 11 Years 7 Months | Current |
|
Vinod Kumar Sharma
Also directs:
Aveo India Healthcare Private Limited, Westfin International Private Limited, Appearance Infrastructure Private Limited and 2 more
|
Director | 28 Mar 2018 | 8 Years 4 Months | Current |
| Shivani Sharma | Additional Director | 04 Oct 2024 | 1 Years 10 Months | Current |
Financials of Meyonex Pharmaceuticals Limited FY 2024 filings available
Meyonex Pharmaceuticals Limited reported revenue of ₹108.15 Cr (down 19.00% YoY) for FY 2025.
Ten-year financial statements for Meyonex Pharmaceuticals Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Meyonex Pharmaceuticals Limited
Shareholding and ownership data for Meyonex Pharmaceuticals Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Meyonex Pharmaceuticals Limited
Meyonex Pharmaceuticals Limited has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2024. The corporate group structure reflects Meyonex Pharmaceuticals Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Aveo India Healthcare Private Limited | U46497MH2024PTC420637 | Locked |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Meyonex Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Oct 2023 | Others | ₹2.41 Cr | Open |
| 26 Sep 2023 | Others | ₹11 Cr | Open |
| 26 Sep 2023 | Others | ₹6.11 Cr | Open |
| 08 Feb 2023 | Others | ₹1.5 Cr | Open |
| 20 Apr 2021 | Hdfc Bank Limited | ₹25 Lakh | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Meyonex Pharmaceuticals Limited
Meyonex Pharmaceuticals Limited has a workforce of 48 employees as of Jul 31, 2025.
Employee and EPFO history for Meyonex Pharmaceuticals Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Meyonex Pharmaceuticals Limited
GST registrations and filing compliance for Meyonex Pharmaceuticals Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Meyonex Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts for Meyonex Pharmaceuticals Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Meyonex Pharmaceuticals Limited
MSME payment history for Meyonex Pharmaceuticals Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Meyonex Pharmaceuticals Limited
Corporate group structure for Meyonex Pharmaceuticals Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Meyonex Pharmaceuticals Limited
MCA filings and documents for Meyonex Pharmaceuticals Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Meyonex Pharmaceuticals Limited
Frequently Asked Questions about Meyonex Pharmaceuticals Limited
Meyonex Pharmaceuticals Limited is an active public limited company in the pharma sector based in Palghar, Maharashtra, India. It was incorporated on 17 January 2015 (11+ years old) and is registered under CIN U74120MH2015PLC261024. The company has 48 employees.
Meyonex Pharmaceuticals Limited reported revenue of ₹108.15 Cr for FY 2025 (down 19.00% YoY).
The current directors of Meyonex Pharmaceuticals Limited are:
- Arvind Awadhnath Sharma - Director
- Vinod Kumar Sharma - Director
- Shivani Sharma - Additional Director
The primary industry of Meyonex Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes, Meyonex Pharmaceuticals Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Meyonex Pharmaceuticals Limited can be reached at the registered office: Plot No C – 13 Midc Tarapur Palghar, Maharashtra, India – 401506, or through the website aveo.in.